Latest: FDA Approves New Biosimilar for Oncology Treatment

Reach7 Diabetes Studios and Trileas Partner to Launch CARES Program for At-Risk Communities

0 Mins
What You Should Know: – Reach7 Diabetes Studios has announced that Trileas is the first official sponsor and founding member of its CARES Program. The program is a third-party sponsored initiative that provides screenings for high-risk individuals and subsidized memberships for those most in need. – The partnership with Trileas, a company dedicated to delivering ... Read More
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago